Intelligent bio solutions secures major drug testing tender with leading london transport operator

New york, july 30, 2025 (globe newswire) -- intelligent bio solutions inc. (nasdaq: inbs) ("inbs" or the "company"), a medical technology company delivering intelligent, rapid, non-invasive testing solutions, today announced it has secured a major contract with one of london's largest public transport operators, spanning 14 operational sites in greater london and employing over 4,400 staff. inbs's intelligent fingerprinting drug screening system will be deployed across a multi-garage bus network that carries over one million passengers daily.
INBS Ratings Summary
INBS Quant Ranking